Compare LLYVA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLYVA | BIO |
|---|---|---|
| Founded | 1991 | 1952 |
| Country | United States | United States |
| Employees | 54700 | 7450 |
| Industry | Broadcasting | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.1B |
| IPO Year | N/A | N/A |
| Metric | LLYVA | BIO |
|---|---|---|
| Price | $98.02 | $291.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $339.75 |
| AVG Volume (30 Days) | 98.5K | ★ 273.6K |
| Earning Date | 02-27-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.59 |
| Revenue Next Year | $5.71 | $3.21 |
| P/E Ratio | ★ N/A | $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $63.86 | $211.43 |
| 52 Week High | $99.82 | $343.12 |
| Indicator | LLYVA | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 59.60 | 64.35 |
| Support Level | $77.49 | $256.85 |
| Resistance Level | $98.57 | $311.09 |
| Average True Range (ATR) | 3.15 | 7.57 |
| MACD | 0.61 | 2.28 |
| Stochastic Oscillator | 89.44 | 90.94 |
Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.